Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02401347
Title Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Melinda Telli
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST